Suspected fatal drug interaction between citalopram and cocaine

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

MHRA received a coroner's report about a case of suspected drug interaction between citalopram and cocaine resulting in a fatal subarachnoid haemorrhage.

Cocaine can cause hypertension and an additive increased bleeding risk in combination with citalopram.

Prescribers ...

Recommended for you

  • Drug Updates
  • 1 comment

Daclizumab (Zinbryta▼) in multiple sclerosis: Review patients for liver function currently on treatment

Read more
  • Drug Updates
  • 1 comment

Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): Risk of graft rejection

Read more
  • Drug Updates
  • 1 comment

Bendamustine (Levact): Increased mortality when used in combination treatment outside the approved indications

Read more
  • Drug Updates
  • 1 comment

Denosumab (Prolia, Xgeva▼): Risk of osteonecrosis of jaw and external auditory canal

Read more
  • Drug Updates
  • 1 comment

Yellow Card Scheme Website: Report any side effects or safety concerns with e-cigarettes and e-liquids

Read more
  • Drug Updates
  • no comment

Brimonidine gel (Mirvaso): Risk of cardiovascular events if applied to damaged skin

Read more
  • Drug Updates
  • no comment

Restrictions to manage the risk for misuse of pseudoephedrine and ephedrine to be continued

Read more
  • Drug Updates
  • 1 comment

Finasteride 1 mg (Propecia): Reports of depression and suicidal thoughts in men

Read more
  • Drug Updates
  • 1 comment

Valproate (Epilim▼, Depakote▼): High risk of neurodevelopmental disability and birth defects

Read more
  • Drug Updates
  • 1 comment

Ponatinib (Iclusig▼): Risk of vascular arterial occlusion is dose-dependent

Read more
  • Drug Updates
  • 1 comment

Multiple sclerosis: Rebound syndrome after stopping fingolimod (Gilenya▼) or switching therapy

Read more
  • Drug Updates
  • 1 comment

Canagliflozin (Invokana▼): Increased risk of lower limb amputation

Read more
  • Drug Updates
  • 1 comment

Pilot website to report adverse reactions of psychoactive substances

Read more
  • Drug Updates
  • 1 comment

Idelalisib (Zydelig▼): updated safety information on risk of infection

Read more
  • Drug Updates
  • 1 comment

Levonorgestrel-containing emergency contraceptives: interaction with hepatic enzyme inducers

Read more
  • Drug Updates
  • 1 comment

Posaconazole (Noxafil): tablets and oral suspension not interchangable

Read more
  • Drug Updates
  • 1 comment

Lonsurf ▼(trifluridine/tipiracil) approved for colorectal cancer chemotherapy

Read more
  • Drug Updates
  • no comment

Riociguat (Adempas) contraindicated in pulmonary hypertension associated with idiopathic interstitial pneumonias

Read more
  • Drug Updates
  • 1 comment

N-acetylcysteine interference with Siemens assays: false-low test results

Read more
  • Drug Updates
  • 1 comment

Rare reports of calciphylaxis in patients taking warfarin

Read more
  • Drug Updates
  • 1 comment

Suspected fatal drug interaction between citalopram and cocaine

Read more
  • Drug Updates
  • 1 comment

Epclusa (sofosbuvir/velpatasvir) approved for treatment of chronic HCV infection

Read more
  • Drug Updates
  • 1 comment

Duavive (conjugated oestrogens/ bazedoxifene) approved for treatment of menopausal symptoms

Read more
  • Drug Updates
  • 1 comment

Hyoscine butylbromide: serious adverse effects in cardiac patients

Read more
  • Drug Updates
  • 1 comment

Drug safety alert: Risk of diabetic ketoacidosis with SGLT2 inhibitors

Read more
  • Drug Updates
  • 1 comment

Drug safety update: Risk of progressive multifocal leukoencephalopathy with dimethyl fumarate (Tecfidera)

Read more
  • Drug Updates
  • 1 comment

Drug safety alert: Risks of PML, basal-cell carcinoma, and opportunistic infections associated with Fingolimod (Gilenya▼)

Read more
  • Drug Updates
  • 1 comment

Drug safety alert: Minimizing cardiac side effects associated with concomitant use of apomorphine and domperidone

Read more
  • Drug Updates
  • 1 comment

Apremilast (Otezla▼): risk of psychiatric symptoms

Read more
  • Drug Updates
  • 1 comment

Direct-acting antivirals for HCV and vitamin K antagonists: risk of interaction

Read more